<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for TSRX</title>
    <link />
    <description>Headlines for Trius Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Cubist, Optimer, Trius: Antibiotic Deal Making On Tap</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11930121/1/cubist-optimer-trius-antibiotic-deal-making-on-tap.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 22 May 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Trius Patent Intrigues Investors, And Perhaps Cubist Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1439971-trius-patent-intrigues-investors-and-perhaps-cubist-pharmaceuticals.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 09:57:43 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3592324/stocks-hitting-52-week-highs.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 10:36:53 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics: New, Positive Dimension For Investment Outlook</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431601-trius-therapeutics-new-positive-dimension-for-investment-outlook.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 13 May 2013 18:27:14 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics Remains One Of Our Best Ideas - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98889/trius-therapeutics-remains-one-of-our-best-ideas.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 09:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: BRK.B FB TSRX</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913728/1/cramers-top-stock-picks-brkb-fb-tsrx.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Sat, 04 May 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Undue Pressure On Trius Creates An Entrance Point</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1393791-undue-pressure-on-trius-creates-an-entrance-point.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 11:08:00 GMT</pubDate>
    </item>
    <item>
      <title>GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1348511-gtx-and-trius-therapeutics-2-top-biotech-buys-for-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 15:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Companies that Can Mend the Biotech Market: Stephen Brozak</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/athx/articles/179026/companies-that-can-mend-the-biotech-market-stephen-brozak/2013-04-11.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Thu, 11 Apr 2013 19:33:27 GMT</pubDate>
    </item>
    <item>
      <title>Trius: Clinical Trials Show Important Differentiation Of Tedizolid From Zyvox</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1328991-trius-clinical-trials-show-important-differentiation-of-tedizolid-from-zyvox.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 09 Apr 2013 04:54:56 GMT</pubDate>
    </item>
    <item>
      <title>Gains In This Biotech Could Soon Become Infectious to Investors</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/26/gains-in-this-biotech-could-soon-become-infectious/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Mar 2013 10:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics Is A Strong Investment Short And Long Term</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1293661-trius-therapeutics-is-a-strong-investment-short-and-long-term.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 16:42:07 GMT</pubDate>
    </item>
    <item>
      <title>Trius: Topline Data From Second Phase III Trial Of Tedizolid Is Imminent</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1282511-trius-topline-data-from-second-phase-iii-trial-of-tedizolid-is-imminent.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Mar 2013 08:54:37 GMT</pubDate>
    </item>
    <item>
      <title>Trius: Phase III Data For Tedizolid Imminent</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1274611-trius-phase-iii-data-for-tedizolid-imminent.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Mar 2013 14:28:16 GMT</pubDate>
    </item>
    <item>
      <title>Oppenheimer Reiterates Outperform Rating, $12 PT on Trius Therapeutics on 4Q12 EPS</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3413746/oppenheimer-reiterates-outperform-rating-12-pt-on-trius-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 13 Mar 2013 13:58:51 GMT</pubDate>
    </item>
    <item>
      <title>4 Stocks Under $10 Spiking Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-stocks-under-10-spiking-higher.html-0.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 05 Mar 2013 14:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Trius: Establishing A Compelling Case For Tedizolid</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1247791-trius-establishing-a-compelling-case-for-tedizolid.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 05 Mar 2013 12:27:58 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1245551-trius-therapeutics-new-msra-treatment-could-bring-billions-in-revenues.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 05 Mar 2013 09:28:00 GMT</pubDate>
    </item>
    <item>
      <title>Upcoming Catalysts For These BioPharmas Provide Potential Upside</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1204161-upcoming-catalysts-for-these-biopharmas-provide-potential-upside.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Feb 2013 08:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Ram Selvaraju: Fall In Love With These Biotech Stocks</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1185981-ram-selvaraju-fall-in-love-with-these-biotech-stocks.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Feb 2013 17:29:14 GMT</pubDate>
    </item>
  </channel>
</rss>
